Approval · Notice of Compliance 37462 · 2026
BRUKINSA: Notice of Compliance 37462
Issued May 1, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37462
- Date
- May 1, 2026
- Company
- Beone Medicines I GmbhBasel, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph as per advisement letter
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRUKINSA | Not yet assigned | — |
Medicinal ingredients
- ZANUBRUTINIB 80 MG per CAP
- ZANUBRUTINIB 160 MG per TAB